Yubing Li

668 total citations · 1 hit paper
28 papers, 446 citations indexed

About

Yubing Li is a scholar working on Molecular Biology, Complementary and alternative medicine and Oncology. According to data from OpenAlex, Yubing Li has authored 28 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Oncology. Recurrent topics in Yubing Li's work include Traditional Chinese Medicine Studies (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). Yubing Li is often cited by papers focused on Traditional Chinese Medicine Studies (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). Yubing Li collaborates with scholars based in China, Germany and United Kingdom. Yubing Li's co-authors include Jinhao Zeng, Xinyu Deng, Qichao Hu, Yuan Chen, Xiao Ma, Xiang Liu, Yanling Zhao, Qidi Ai, Shasha Liu and Zunfu Ke and has published in prestigious journals such as Molecules, Medicine and Frontiers in Pharmacology.

In The Last Decade

Yubing Li

25 papers receiving 445 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation

2023 99 citations Qichao Hu, Yuan Chen et al. Biomedicine & Pharmacotherapy profile →

Peers

Yubing Li

CAM

EPIDE

ONCOL

IMMUN

Qingling Li China

Hongyang Liu China

Bingbing Zhu China

Lixia Bai China

Kangwook Lee South Korea

Zhaolin Sun China

Shaoqiang Zhang China

Ye Huang China

Qingsong Sun China

Qingling Li China

Yubing Li

186 ×0.9

76 ×1.0

CAM

47 ×0.7

EPIDE

77 ×1.3

ONCOL

62 ×1.1

IMMUN

Citations per year, relative to Yubing Li Yubing Li (= 1×) peers Qingling Li

Countries citing papers authored by Yubing Li

Since Specialization

Citations

This map shows the geographic impact of Yubing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubing Li more than expected).

Fields of papers citing papers by Yubing Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubing Li. The network helps show where Yubing Li may publish in the future.

Co-authorship network of co-authors of Yubing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yubing Li. A scholar is included among the top collaborators of Yubing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubing Li. Yubing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiali, et al.. (2025). Development and validation of a prostate cancer risk prediction model for the elevated PSA population. Frontiers in Oncology. 15. 1599266–1599266.

Deng, Xinyu, Yubing Li, Yuan Chen, et al.. (2024). Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK/mTOR signaling pathway. Cellular & Molecular Biology Letters. 29(1). 119–119. 33 indexed citations

Zhang, Wenhao, et al.. (2024). Spontaneous rupture and hemorrhage of renal epithelioid angiomyolipoma misdiagnosed to renal carcinoma: a case report. Journal of Medical Case Reports. 18(1). 425–425.

Hu, Qichao, Yuan Chen, Wenwen Zhang, et al.. (2024). Dehydroevodiamine targeting IKKβ to alleviate acute gastric injury via inhibiting the p65/NLRP3 axis. Phytomedicine. 134. 155963–155963. 5 indexed citations

Li, Yubing, et al.. (2023). Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1088614–1088614. 2 indexed citations

Li, Yubing, Xinyu Deng, Huiling Xiong, et al.. (2023). Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review. Frontiers in Pharmacology. 14. 1278014–1278014. 6 indexed citations

He, Xuan, Yubing Li, Xinyu Deng, Xiaolin Xiao, & Jinhao Zeng. (2023). Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses. Frontiers in Pharmacology. 14. 1230783–1230783. 17 indexed citations

Hu, Qichao, Yuan Chen, Xinyu Deng, et al.. (2023). Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation. Biomedicine & Pharmacotherapy. 159. 114252–114252. 99 indexed citations breakdown →

Hu, Sihan, et al.. (2023). Protective role of baicalin in the dynamic progression of lung injury to idiopathic pulmonary fibrosis: A meta-analysis. Phytomedicine. 114. 154777–154777. 9 indexed citations

10.

Zhou, Xiuman, Liwei Pang, Mingshuang Wang, et al.. (2022). Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer. Cancer Immunology Immunotherapy. 72(4). 985–1001. 4 indexed citations

11.

Wang, Zhiwei, Ling Ran, Chunxia Chen, et al.. (2021). Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma. Vaccines. 9(10). 1118–1118. 2 indexed citations

12.

Dong, Yu, Yanfeng Gao, Yubing Li, et al.. (2021). Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis. Journal of Immunology Research. 2021. 1–13. 4 indexed citations

13.

Long, Lingli, Tengfei Long, Xiaofang Lu, et al.. (2021). Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. Journal for ImmunoTherapy of Cancer. 9(12). e003973–e003973. 44 indexed citations

14.

Li, Yubing, Ling Ran, Yu Dong, et al.. (2021). Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy of non-microsatellite instability-high colorectal cancer. Science China Life Sciences. 65(3). 572–587. 9 indexed citations

15.

Li, Yubing, et al.. (2018). Rare foreign body in bladder. Medicine. 97(17). e0519–e0519. 11 indexed citations

16.

Yang, Kuo, Runshun Zhang, Liyun He, et al.. (2017). Multistage analysis method for detection of effective herb prescription from clinical data. Frontiers of Medicine. 12(2). 206–217. 13 indexed citations

17.

Li, Yubing, et al.. (2016). New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles. Medicine. 95(20). e3691–e3691. 13 indexed citations

18.

Liu, Shasha, et al.. (2016). The cardioprotective effect of dihydromyricetin prevents ischemia–reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways. APOPTOSIS. 21(12). 1366–1385. 70 indexed citations

19.

Zhou, Xuezhong, Yubing Li, Yonghong Peng, et al.. (2014). Clinical phenotype network: the underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine. Frontiers of Medicine. 8(3). 337–346. 23 indexed citations

20.

Li, Yubing, Kai Yang, Qiqi Mao, et al.. (2009). Inhibition of TGF-β receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase. International Urology and Nephrology. 42(2). 315–323. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact